Literature DB >> 30519799

Metvan, bis(4,7-Dimethyl-1,10-phenanthroline)sulfatooxidovanadium(IV): DFT and Spectroscopic Study-Antitumor Action on Human Bone and Colorectal Cancer Cell Lines.

Ignacio E León1, María C Ruiz1, Carlos A Franca1, Beatriz S Parajón-Costa1, Enrique J Baran2.   

Abstract

The complex bis(4,7-dimethyl-1,10-phenantroline)sulfatooxidovanadium(IV), commonly known as Metvan, was prepared using a known synthetic procedure. Its optimized molecular structure was obtained by DFT calculations, as it was impossible to grow single crystals adequate for a crystallographic study. The complex was also characterized by a detailed analysis of its infrared spectrum, supported by the theoretical calculations, and also by some data derived from its Raman spectrum. In addition, cytotoxicity studies were performed using human osteosarcoma (MG-63) and human colorectal adenocarcinoma (HT-29) cell lines. The results show that Metvan impaired cell viability of both cancer cell lines in a low concentration range (0.25-5.0 μM).

Entities:  

Keywords:  DFT calculations; FTIR spectrum; Human bone and colorectal cancer cell lines; Metvan; Oxidovanadium(IV)

Mesh:

Substances:

Year:  2018        PMID: 30519799     DOI: 10.1007/s12011-018-1597-2

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  3 in total

1.  Toxicity of Nanocomplexes Containing Gadolinium Orthovanadate Nanoparticles and Cholesterol.

Authors:  Anatoliy Goltsev; Natalia Babenko; Yuliia Gaevska; Mykola Bondarovych; Tetiana Dubrava; Lyudmila Ostankova; Nataliia Volkova; Vladimir Klochkov
Journal:  Biol Trace Elem Res       Date:  2022-01-13       Impact factor: 4.081

2.  Synthesis, Crystal Structure, and Computational Methods of Vanadium and Copper Compounds as Potential Drugs for Cancer Treatment.

Authors:  Nidia D Corona-Motolinia; Beatriz Martínez-Valencia; Lisset Noriega; Brenda L Sánchez-Gaytán; Miguel Ángel Méndez-Rojas; Francisco J Melendez; María Eugenia Castro; Enrique González-Vergara
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

Review 3.  Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.

Authors:  Pedro Farinha; Jacinta O Pinho; Mariana Matias; M Manuela Gaspar
Journal:  Drug Deliv Transl Res       Date:  2021-02-22       Impact factor: 4.617

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.